Delivery Order SPE2DB22D2211-SPE2DB25FSGCV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,119.56 to AmerisourceBergen Drug Corp for Diclofenac Sodium 1% Gel in 100-gram quantities. This contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award authority. The delivery order is set to complete by September 19, 2025, one day after the award date of September 18, 2025. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Diclofenac Sodium 1% Gel (100GM) with a ceiling value of $1,466.40. This non-competitive, firm fixed-price delivery order was executed on September 25, 2025, with an ultimate completion date of September 26, 2025. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,613.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Diclofenac Sodium 1% Gel in 100-gram units, with an ultimate completion date of September 22, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Diclofenac Sodium 1% Gel 100GM valued at $3,276.00. This firm fixed price delivery order was competitively awarded with no set-aside designation and carries an ultimate completion date of August 18, 2025. The award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- This is a $1,363.83 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 grams of Diclofenac Sodium 1% Gel, a topical anti-inflammatory medication. The award is not set aside and has an ultimate completion date of June 26, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a $1,466.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Diclofenac Sodium 1% Gel 100GM, a nonsteroidal anti-inflammatory topical medication. The contract was competitively awarded without a set-aside designation and carries an ultimate completion date of September 29, 2025. Performance will occur at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $283.20 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for Diclofenac Sodium 1% Gel 100gm. The single day contract runs from September 19-20, 2023, with performance taking place in Conshohocken, Pennsylvania. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense globally, this order for a topical nonsteroidal anti-inflammatory drug gel supports the Agency's mission to provide critical...
- This delivery order was awarded by the Defense Logistics Agency Troop Support Medical (DLA) to Amerisourcebergen Drug Corp for $141,600 to supply 100 grams of the generic nonsteroidal anti-inflammatory drug diclofenac sodium gel 1% under a firm fixed price contract. Place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all items to be delivered within a one day period concluding on July 18, 2023. As a major provider of pharmaceuticals and medical supplies,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred forty-one thousand six hundred sixty dollars to Amerisourcebergen Drug Corporation for Diclofenac Sodium 1% Gel 100gm. The single day contract has a period of performance from August 7 through August 8, 2023 at Amerisourcebergen's facility in Conshohocken, Pennsylvania. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for a topical nonsteroidal...
- The Defense Logistics Agency awarded a $141,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Diclofenac Sodium 1% Gel 100gm. The order was placed under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DOD medical treatment facilities. Performance will take place in Conshohocken, Pennsylvania from August 25-28, 2023. No subcontractors or set aside designations were identified. This order supports DLA's mission to provide...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSGCVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Diclofenac Sodium 1% Gel in 100-gram units, with a ceiling value of $1,173.12. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by September 29, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The Diclofenac Sodium delivery represents a continuation of the company's ongoing role in fulfilling DLA's pharmaceutical requirements across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/26/25 |